180 related articles for article (PubMed ID: 37023867)
1. Liposarcoma of the pleural cavity.
Kawai T; Nakashima H; Washimi K; Yokose T; Matsuo T; Nakayama M; Shinohara N; Kuroda H; Ishida K; Akiba J; Ishikawa M; Urabe S; Shiraishi J; Shiraishi T; Sakamoto A; Matsukuma S
Hum Pathol; 2023 Jun; 136():105-113. PubMed ID: 37023867
[TBL] [Abstract][Full Text] [Related]
2. [Clinical value of fluorescence
Wang W; Li X; Liu P; Dong Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):228-233. PubMed ID: 37042132
[TBL] [Abstract][Full Text] [Related]
3. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.
Kammerer-Jacquet SF; Thierry S; Cabillic F; Lannes M; Burtin F; Henno S; Dugay F; Bouzillé G; Rioux-Leclercq N; Belaud-Rotureau MA; Stock N
Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521
[TBL] [Abstract][Full Text] [Related]
4. Detection of
Rekhi B; Karnik N; Agrawal R; Shetty O; Patkar S
Indian J Pathol Microbiol; 2022; 65(1):65-75. PubMed ID: 35074968
[TBL] [Abstract][Full Text] [Related]
5. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X
Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706
[TBL] [Abstract][Full Text] [Related]
6. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L
Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
[TBL] [Abstract][Full Text] [Related]
7. [Well-differentiated/dedifferentiated liposarcoma associated with myxoid-like morphology: a clinicopathological and molecular genetic characteristics analysis of 34 cases].
Xue S; Liu QY; Gou XN; Zhao YW; Cheng Q; Kong LF
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):168-173. PubMed ID: 38281785
[No Abstract] [Full Text] [Related]
8. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.
Kuczkiewicz-Siemion O; Wiśniewski P; Dansonka-Mieszkowska A; Grabowska-Kierył M; Olszewska K; Goryń T; Prochorec-Sobieszek M; Rutkowski P; Szumera-Ciećkiewicz A
Pathol Res Pract; 2021 Sep; 225():153555. PubMed ID: 34325315
[TBL] [Abstract][Full Text] [Related]
9. Atypical lipomatous tumor/well differentiated liposarcoma and related mimics with updates. When is molecular testing most cost-effective, necessary, and indicated?
Kilpatrick SE
Hum Pathol; 2024 May; 147():82-91. PubMed ID: 38135062
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms.
Weaver J; Downs-Kelly E; Goldblum JR; Turner S; Kulkarni S; Tubbs RR; Rubin BP; Skacel M
Mod Pathol; 2008 Aug; 21(8):943-9. PubMed ID: 18500263
[TBL] [Abstract][Full Text] [Related]
11. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.
Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A
Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411
[TBL] [Abstract][Full Text] [Related]
12. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
[TBL] [Abstract][Full Text] [Related]
13. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
[TBL] [Abstract][Full Text] [Related]
14. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.
Binh MB; Sastre-Garau X; Guillou L; de Pinieux G; Terrier P; Lagacé R; Aurias A; Hostein I; Coindre JM
Am J Surg Pathol; 2005 Oct; 29(10):1340-7. PubMed ID: 16160477
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor.
Kashima T; Halai D; Ye H; Hing SN; Delaney D; Pollock R; O'Donnell P; Tirabosco R; Flanagan AM
Mod Pathol; 2012 Oct; 25(10):1384-96. PubMed ID: 22699518
[TBL] [Abstract][Full Text] [Related]
16. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma With Features Mimicking Spindle Cell Lipoma.
Jebastin JAS; Perry KD; Chitale DA; Mott MP; Sanchez J; Fritchie KJ; Palanisamy N; Williamson SR
Int J Surg Pathol; 2020 May; 28(3):336-340. PubMed ID: 31672072
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of MDM2 and DDIT3 Fluorescence In Situ Hybridization in Liposarcoma Classification: A Single-Institution Experience.
Cho J; Lee SE; Choi YL
Korean J Pathol; 2012 Apr; 46(2):115-22. PubMed ID: 23109990
[TBL] [Abstract][Full Text] [Related]
18. Primary dermal pleomorphic liposarcoma: utility of adipophilin and MDM2/CDK4 immunostainings.
Ramírez-Bellver JL; López J; Macías E; Alegría-Landa V; Gimeno I; Pérez-Plaza A; Kutzner H; Requena L
J Cutan Pathol; 2017 Mar; 44(3):283-288. PubMed ID: 27778364
[TBL] [Abstract][Full Text] [Related]
19. Lipomas of the Oral Cavity: Utility of MDM2 and CDK4 in Avoiding Overdiagnosis as Atypical Lipomatous Tumor.
Stojanov IJ; Mariño-Enriquez A; Bahri N; Jo VY; Woo SB
Head Neck Pathol; 2019 Jun; 13(2):169-176. PubMed ID: 29748845
[TBL] [Abstract][Full Text] [Related]
20. Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma.
Erickson-Johnson MR; Seys AR; Roth CW; King AA; Hulshizer RL; Wang X; Asmann YW; Lloyd RV; Jacob EK; Oliveira AM
Mod Pathol; 2009 Dec; 22(12):1541-7. PubMed ID: 19820690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
